BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...

Syros noted that SELCT-MDS-1 Phase III trial’s failure to meet its endpoint constituted a default event under its secured ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

NHS England states that the tablet is as effective as vapes in helping people stop smoking, and even better than ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

The AUGMENT-101 trial evaluated the safety and efficacy of revumenib in adults with relapsed or refractory mutant NPM1 AML.

Ontada has entered into a strategic partnership with health data platform Datavant to enable quick access to oncology ...

Lyophilization is a practical and essential process for the production of biologics and other sensitive compounds. Image ...

Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...